(Q43084698)

13 November 2017

Immunotherapy of HPV-associated head and neck cancer: Critical parameters (English)

1 reference

13 November 2017

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

10

1 reference

13 November 2017

5

Magali Terme

1 reference

13 November 2017

Mevyn Nizard

1

1 reference

13 November 2017

Federico Sandoval

2

1 reference

13 November 2017

Cecile Badoual

3

1 reference

13 November 2017

Helene Pere

4

1 reference

13 November 2017

Stephane Hans

6

1 reference

13 November 2017

Nadine Benhamouda

7

1 reference

13 November 2017

Clemence Granier

8

1 reference

13 November 2017

Daniel Brasnu

9

1 reference

13 November 2017

language of work or name

1 reference

16 April 2013

1 reference

13 November 2017

1 reference

13 November 2017

2

1 reference

13 November 2017

6

1 reference

13 November 2017

e24534

1 reference

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716751

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

15 August 2018

1 reference

https://api.crossref.org/works/10.4161%2FONCI.24534

The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FONCI.24534

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FONCI.24534

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FONCI.24534

21 January 2018

Identifiers

DOI

10.4161/ONCI.24534

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

23894716

1 reference